Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer. [electronic resource]
Producer: 20160229Description: 1122-30 p. digitalISSN:- 1465-3621
- Adult
- Aged
- Antimetabolites, Antineoplastic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Asian People
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Drug Administration Schedule
- Drug Combinations
- Female
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms -- drug therapy
- Lung Neoplasms -- drug therapy
- Lymphatic Metastasis
- Male
- Middle Aged
- Odds Ratio
- Oxonic Acid -- administration & dosage
- Pancreatic Neoplasms -- drug therapy
- Peritoneal Neoplasms -- drug therapy
- Randomized Controlled Trials as Topic
- Research Report -- standards
- Tegafur -- administration & dosage
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.